AF
RIGL icon

Amalgamated Financial’s Rigel Pharmaceuticals RIGL Stock Holding History

Amalgamated Financial’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$83K Buy
+2,782
New +$75.3K ﹤0.01% 2223

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Amalgamated Financial's RIGL Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Rigel Pharmaceuticals (RIGL) in Q1 2022: 2,782 shares worth $83K. The stake represents ﹤0.01% of the portfolio and ranks #2223 among its holdings.

163 funds tracked by Wall St. Rank hold RIGL as of Q1 2022.

  • Amalgamated Financial held 2,782 shares of Rigel Pharmaceuticals worth $83K as of Q1 2022.
  • Rigel Pharmaceuticals was a new Amalgamated Financial position in Q1 2022.
  • Rigel Pharmaceuticals made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2223 holding.
  • 163 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.